Paris, France

Vincent Gerusz

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Paris, FR (2013 - 2018)
  • Neuvecelle, FR (2019)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Vincent Gerusz

Introduction

Vincent Gerusz is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 11 patents to his name, Gerusz has established himself as a key figure in innovative pharmaceutical research.

Latest Patents

Gerusz's latest patents include "Heteroaromatic derivatives and their use as pharmaceuticals." This invention relates to specific compounds and their salts, which have applications in antibacterial prevention and therapy. Another significant patent is "Antibacterial compounds and biological applications thereof," which details various compounds and their potential uses in enhancing host innate immunity and combating bacterial infections.

Career Highlights

Throughout his career, Vincent Gerusz has worked with several companies, including Fab Pharma S.a.s. and Mutabilis. His work has focused on the synthesis and application of novel compounds that address critical health challenges. His innovative approaches have led to advancements in pharmaceutical formulations and therapeutic strategies.

Collaborations

Gerusz has collaborated with notable colleagues such as Alexis Denis and Mayalen Oxoby. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Vincent Gerusz's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the development of effective antibacterial therapies and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…